Kristina Burow, Director, 10% Owner at Neumora Therapeutics, Inc. (NMRA), bought 1,915,700 shares at $2.61 ($5.0M) on 2025-10-27, disclosed to the SEC on 2025-10-29.
Open-market purchase of $5.0M NMRA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| MTSR | BUY | 2025-02-03 | $40.0M | — | Filing → |
| BOLD | BUY | 2024-04-04 | $3.2M | — | Filing → |
| SANA | BUY | 2024-02-12 | $8.0M | — | Filing → |